Innovent Biologics Inc (OTC:IVBXF) and Sanofi SA (NASDAQ:SNY) have collaborated to develop and commercialize two Sanofi clinical-stage oncology assets – Phase 3 SAR408701…
For the first time since April, purchase mortgage rates dropped below the 5% level, reflecting the Federal Reserve’s monetary policy that has led the U.S economy to a “technical recession.”
Astria Therapeutics (NASDAQ: ATXS) announced initiation of a Phase 1a clinical trial of STAR-0215 in healthy subjects.
STAR-0215 is designed to provide long-acting, effective attack prevention for hereditary angioedema (HAE), with dosing once every three months or longer.